Based on our Pharmacor advisory service entitled Fibromyalgia, Decision Resources is offering an exclusive Pharmacor analyst call entitled Despite Safety Concerns, Sodium Oxybate is Poised for Approval in the U.S. for Fibromyalgia: Will It See Any Uptake in Primary Care? Because this analyst call features major updates, it is ONLY available to purchasers of this Pharmacor advisory service.

 

This analyst call was held on February 25, 2010. Contact us to learn how you can purchase this Pharmacor advisory service and access a recorded playback of this event.

Click here to view the invite.